Form 4: Avanos Medical Director Gary Blackford Acquires 12,003 Shares Through Restricted Stock Units
SEC Form 4 Filing
Director Gary Blackford acquired 12,003 shares of Avanos Medical stock through restricted stock units on January 2, 2025.
Summary
- Gary Blackford, a director at Avanos Medical, Inc., acquired 12,003 shares of common stock on January 2, 2025.
- The shares were acquired through restricted stock units (RSUs) as part of the company's Outside Directors' Compensation Plan.
- The acquisition price for the shares was $0, indicating they were granted as compensation.
- Following this transaction, Mr. Blackford's total holdings in Avanos Medical increased to 71,593 shares.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There are no negative implications.
Positives
- The acquisition of shares by a director demonstrates confidence in the company's future.
- The use of restricted stock units aligns director compensation with shareholder interests.
Industry Context
This is a routine filing related to director compensation and is common practice for publicly traded companies. It reflects standard procedures for aligning director interests with those of shareholders.
Comparison to Industry Standards
- The use of restricted stock units for director compensation is a common practice among publicly traded companies, including those in the medical device sector.
- Companies like Medtronic and Stryker also use similar compensation methods to align director interests with shareholder value.
- The number of shares granted is within the typical range for director compensation packages.
Stakeholder Impact
- The share acquisition by a director may be viewed positively by shareholders as it indicates confidence in the company's future performance.
- The use of RSUs aligns director compensation with shareholder interests, potentially leading to better long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Date of the transaction where Gary Blackford acquired 12,003 shares of Avanos Medical stock. |
| 01/06/2025 | Date the Form 4 was signed. |
Keywords
Avanos Medical, Director, Gary Blackford, Restricted Stock Units, Share Acquisition, Compensation Plan, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.